Dr. Windon is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
675 Nelson Rising Lane
Suite 190
San Francisco, CA 94158Phone+1 415-514-8507
Education & Training
- University of California (San Francisco)Fellowship, Behavioral Neurology, 2019 - 2021
- UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Neurology, 2016 - 2019
- Rutgers Robert Wood Johnson Medical SchoolClass of 2015
- Princeton UniversityBA, Molecular Biology, 2006 - 2010
Certifications & Licensure
- CA State Medical License 2019 - 2026
- PA State Medical License 2015 - 2016
- American Board of Psychiatry and Neurology Neurology
Publications & Presentations
PubMed
- Amyloid PET in Sporadic Early- Versus Late-Onset Alzheimer's Disease: Comparison of the LEADS and ADNI Cohorts.Julien Lagarde, Piyush Maiti, Daniel R Schonhaut, Ganna Blazhenets, Jiaxiuxiu Zhang
Annals of Neurology. 2025-03-17 - F-MK-6240 tau PET in patients at-risk for chronic traumatic encephalopathy.Michael L Alosco, Jhony Mejía Pérez, Julia E Culhane, Ranjani Shankar, Christopher J Nowinski
Molecular Neurodegeneration. 2025-02-25 - Navigating barriers to dementia specialty care among vulnerable populations: Insight from a multidiscipline care navigation team.Charles C Windon, Stephanie Pun, Mitchel Erickson, Ashley J Jackson, Hannah Ruben
Journal of Alzheimer's Disease Reports. 2025-01-31
Journal Articles
- Racial and Ethnic Differences in Amyloid PET Positivity in Individuals With Mild Cognitive Impairment or DementiaA Secondary Analysis of the Imaging Dementia–Evidence ...Wilkins CH, Windon CC, Dilworth-Anderson P, et al., JAMA, 10/3/2022
- Perils of Race-Based Norms in Cognitive TestingCharles Windon, MD, JAMA Neurology
Press Mentions
- Fewer Asian, Black, Hispanic Patients Eligible for Drugs That May Delay Alzheimer’s ProgressionOctober 14th, 2022
- Neuroscientists to Reveal New Insights into Alzheimer’sOctober 20th, 2023
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: